4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-20-000006
President and CEO gave up 3,122 shares (to pay taxes)
- President and CEO acquired 10,395 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Luly Jay R. · President and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-02-12 | Grant or award : show line 1 in the form | +1,485 | 643,901 | D | ||
| 2020-02-12 | Grant or award : show line 2 in the form | +8,910 | 652,811 | D | ||
| 2020-02-12 | Shares withheld for taxes : show line 3 in the form | −3,122 | $52.76 | $164,717 | 649,689 | D |
Loading xslF345X03/edgar.xml…